ライフサイエンスコーパス: erythroderma

1 patients with atopic dermatitis with severe erythroderma.

2 m classical bullous congenital ichthyosiform erythroderma.

3 ts, which were different from other forms of erythroderma.

4 yperkeratosis, palmoplantar keratoderma, and erythroderma.

5 ell populations and cytokines in subtypes of erythroderma.

6 and Th1 skewing in congenital ichthyosiform erythroderma.

7 yndrome is characterized by neonatal scaling erythroderma, a bamboolike hair defect, a substantial sk

8 ve skin disorder characterized by congenital erythroderma, a specific hair-shaft abnormality, and ato

9 th cases of bullous congenital ichthyosiform erythroderma also due to keratin 1 mutations, which show

10 ratification identified only 1 severe flare (erythroderma) among all flares reported, with no pustula

11 tis, palmoplantar keratoderma, ichthyosiform erythroderma and a high incidence of childhood mortality

12 Subjects with erythroderma and active plaque phenotypes displayed elev

13 nct from those of patients with inflammatory erythroderma and from healthy volunteers.

14 Severe early-onset erythroderma and gut inflammation, with massive tissue i

15 listering and erythroderma in infancy and by erythroderma and ichthyosis thereafter.

16 congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD syndrome), hydrops-

17 Congenital Hemidysplasia with Ichthyosiform erythroderma and Limb Defects (CHILD) syndrome, an X-lin

18 congenital hemidysplasia with ichthyosiform erythroderma and limb defects.

19 [congenital hemidysplasia with ichthyosiform erythroderma and limb defects] syndrome, n = 2) and from

20 A transient worsening of erythroderma and pruritus occurred in 53% of patients wi

21 hyosis, and 18 with congenital ichthyosiform erythroderma) and 40 healthy controls.

22 m abnormalities and a pruritic ichthyosiform erythroderma, are together diagnostic of NLSDI.

23 ne pole and classic congenital ichthyosiform erythroderma at the other.

24 Bullous congenital ichthyosiform erythroderma (BCIE) is characterized by blistering and e

25 y using biopsy samples of psoriasis, AD, and erythroderma belonging to the surgical pathology files o

26 kin disease bullous congenital ichthyosiform erythroderma by gene targeting.

27 d that the index patient had a novel form of erythroderma characterized by increased interleukin (IL)

28 n termed nonbullous congenital ichthyosiform erythroderma (CIE).

29 molecular disease map of chronic idiopathic erythroderma (CIE).

30 ease inhibitor causes congenital exfoliative erythroderma, eczematous-like lesions, and atopic manife

31 lood of a patient with refractory idiopathic erythroderma, erythrodermic patients with Sezary syndrom

32 er characterized by congenital ichthyosiform erythroderma, hair shaft defects and atopy, caused by mu

33 ified in a child with congenital exfoliative erythroderma, hypotrichosis, severe nail dystrophy and f

34 ified in a child with congenital exfoliative erythroderma, hypotrichosis, severe nail dystrophy and f

35 ma (BCIE) is characterized by blistering and erythroderma in infancy and by erythroderma and ichthyos

36 igated the pathogenesis of the ichthyosiform erythroderma in patients from three unrelated kindreds w

37 Chronic erythroderma is a potentially life-threatening condition

38 Congenital erythroderma is a rare and often life-threatening condit

39 Erythroderma is a severe and heterogeneous inflammatory

40 is a severe immunodeficiency associated with erythroderma, lymphoproliferation, elevated IgE, and hyp

41 ts with ichthyosis (congenital ichthyosiform erythroderma, n = 6; lamellar ichthyosis, n = 7; epiderm

42 s from 29 patients (congenital ichthyosiform erythroderma, n = 9; lamellar ichthyosis, n = 8; epiderm

43 Nonbullous congenital ichthyosiform erythroderma (NCIE) is a nonsyndromic form of autosomal

44 yosis linearis circumflexa (NS-ILC) or scaly erythroderma (NS-SE).

45 with little evidence of blood involvement to erythroderma often in association with frank leukemia, a

46 cell lymphoma, including 31 with exfoliative erythroderma or Sezary syndrome and 11 with mycosis fung

47 of the pathophysiological characteristics of erythroderma, psoriasis, and AD and may influence therap

48 equently diagnosed as psoriasis (n = 7), and erythroderma subsequently diagnosed as AD (n = 5).

49 nic psoriasis (n = 20), chronic AD (n = 20), erythroderma subsequently diagnosed as psoriasis (n = 7)

50 at least moderately severe symptoms (diffuse erythroderma, tachycardia, chest tightness, wheezing, fa

51 variant of bullous congenital ichthyosiform erythroderma that has recently been described in two sep

52 The clinical features of erythroderma, trichorrhexis invaginata, and atopic manif

53 tients with CTCL especially individuals with erythroderma where they could exacerbate and/or perpetua

54 howed skin abnormalities, such as congenital erythroderma with a shiny, translucent skin.

55 s, mycosis fungoides (MF), or as exfoliative erythroderma with circulating atypical cells, Sezary syn

56 ls (PBMCs) from patients with advanced CTCL (erythroderma with circulating malignant T cells) and hea

57 This study highlights a novel form of erythroderma with concomitant Th2 and Th17 dysregulation

58 Tg-KLK5 mice developed an exfoliative erythroderma with scaling, growth delay, and hair abnorm